Page last updated: 2024-12-07

3,3'-dithiobis(sulfosuccinimidyl propionate)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,3'-dithiobis(sulfosuccinimidyl propionate): structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID123933
SCHEMBL ID243172
MeSH IDM0109362

Synonyms (26)

Synonym
dtbssp
81069-02-5
1-[3-[[3-(2,5-dioxo-3-sulfopyrrolidin-1-yl)oxy-3-oxopropyl]disulfanyl]propanoyloxy]-2,5-dioxopyrrolidine-3-sulfonic acid
3-pyrrolidinesulfonic acid, 1,1'-[dithiobis[(1-oxo-3,1-propanediyl)oxy]]bis[2,5-dioxo-
85549-78-6
3,3'-dithiobis(sulfosuccinimidyl propionate)
3-pyrrolidinesulfonic acid, 1,1'-(dithiobis((1-oxo-3,1-propanediyl)oxy))bis(2,5-dioxo-
dtssp
FT-0614095
AKOS015898342
SCHEMBL243172
dtssp crosslinker
DTXSID30276271
3,3'-dithiobispropionic acid bis-sulfosuccinimidyl ester
VOTJUWBJENROFB-UHFFFAOYSA-N
3,3'-dithiobis(sulphosuccinimidyl propionate)
mfcd01861949
3,3'-dithiobis(sulfosuccinimidylpropanoate)
1-a[3-a[3-a?2,5-adioxo-a?-asulfopyrrolidin-a?-ayl)oxy-a?-aoxopropyl]disulfanylpropanoyloxy]-a?,5-adioxopyrrolidine-a?-asulfonic acid
C93510
1,1'-((3,3'-disulfanediylbis(propanoyl))bis(oxy))bis(2,5-dioxopyrrolidine-3-sulfonic acid) ,
1-[3-[3-(2,5-dioxo-3-sulfopyrrolidin-1-yl)oxy-3-oxopropyl]disulfanylpropanoyloxy]-2,5-dioxopyrrolidine-3-sulfonic acid
DTXSID701001749
1,1'-{disulfanediylbis[(1-oxopropane-3,1-diyl)oxy]}bis(2,5-dioxopyrrolidine-3-sulfonic acid)
HY-126349
CS-0102759
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (82)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (13.41)18.7374
1990's35 (42.68)18.2507
2000's22 (26.83)29.6817
2010's11 (13.41)24.3611
2020's3 (3.66)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 15.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index15.55 (24.57)
Research Supply Index4.42 (2.92)
Research Growth Index4.78 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (15.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other82 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]